(Total Views: 330)
Posted On: 10/02/2019 10:39:02 AM
Post# of 145248
Exactly, most BP only have failed NASH trials so far and either no NASH pipeline left or only early stage candidates. I haven’t researched the field recently, but recall ICPT, GALT and VKTX with the most promising late stage pipeline drugs still standing.....and GILD drug failed earlier this year.
$100,000 spent to get an extremely drug to phase 2 in NASH could end with an extremely lucrative ROI in the future.
$100,000 spent to get an extremely drug to phase 2 in NASH could end with an extremely lucrative ROI in the future.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.